Cargando…
COVID-19 associated coagulopathy and thrombosis in cancer
Cancer patients are at risk for a more severe COVID-19 infection as well as an adverse outcome of such infection. This may be caused by the cancer itself (e.g haematological malignancies and lung cancer) or due to immune suppression caused by anti-cancer treatment. Severe COVID-19 infections are oft...
Autores principales: | Levi, Marcel, van Es, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134033/ https://www.ncbi.nlm.nih.gov/pubmed/36210564 http://dx.doi.org/10.1016/j.thromres.2021.12.006 |
Ejemplares similares
-
Thrombosis and coagulopathy in COVID‐19: An illustrated review
por: Levi, Marcel, et al.
Publicado: (2020) -
Thrombosis and Coagulopathy in COVID-19
por: Gómez-Mesa, Juan Esteban, et al.
Publicado: (2021) -
COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020) -
Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19
por: Levi, Marcel
Publicado: (2021) -
Proposal of the Definition for COVID-19-Associated Coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2021)